Compare First Citizens BancShares Inc (FCNCA) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs Marsh & McLennan Companies, Inc. — how do they compare? First Citizens BancShares Inc trades at $2,068.39 (market cap $22.94B), while Marsh & McLennan Companies, Inc. trades at $175.76 (market cap $84.31B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 3.7× First Citizens BancShares Inc's market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.24%). Which is the better fit depends on your goals — on Pluang, investors hold First Citizens BancShares Inc for 29 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.
| FCNCA | MRSH | |
|---|---|---|
Market Cap | $22.94B | $84.31B |
Volume | 91,668 | 3,948,947 |
Sector | Sector/Thematic | Financials |
52-Week High | $2.29K | $207.02 |
52-Week Low | $1.64K | $157.32 |
Typical Hold Time | 29 Days | 109 Days |
Dividend Yield | 0.41% | 2.24% |
Enterprise Value | — | $104.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,065.89, down slightly (-0.27%) with a bearish technical outlook. The company demonstrates strong fundamental performance with consistent earnings beats (Q2 2026 EPS of $57.09 vs. $40.69 expected) and robust profitability (25.23% net margin). Recent developments include branch expansions and significant commercial lending activity, though cash flow trends show heavy investment outflows. Analyst sentiment is cautious with 82% hold ratings despite a $2,290 consensus price target suggesting modest upside potential.
FCNCA presents a mixed investment case with solid fundamentals offset by technical weakness and cautious analyst sentiment. The stock offers value characteristics with an 11.08 P/E ratio and dividend income, but faces headwinds from bearish technical indicators and institutional selling pressure. Key risks include execution of expansion strategy and potential margin compression in a competitive banking environment.
Marsh (MRSH) trades at $176.67, up 1.73% today, with a bullish technical trend and strong support at $174. The company shows robust fundamentals, with revenue growing to $26.98B in 2025 and a net income margin of 14.24%. Recent acquisition of Accel Holdings (Business Wire, 2026-10-02) may enhance growth. Earnings have consistently beaten estimates in recent quarters, with Q3 2026 results pending.
Outlook is positive with a consensus price target of $202.71 (MarketBeat, 2026-09-30), offering ~15% upside. Risks include competitive pressures and market volatility. Analyst sentiment is mixed, with 32% buy ratings but 65% hold, suggesting cautious optimism amid solid execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
